Alterity Therapeutics Limited reported AUD15.77M in Cash and Equivalent for its fiscal semester ending in June of 2023.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Arca Biopharma USD 191.52M 76.95M Sep/2026
aTyr Pharma USD 13.14M 3.02M Sep/2026
Bio Path 13.65M 3.37M Sep/2022
Brainstorm Cell Therapeutics USD 22K 7K Jun/2026
Capricor Therapeutics USD 44.28M 23.34M Sep/2026
Cara Therapeutics USD 22.28M 2.42M Sep/2026
CSL USD 2.16B 633M Jun/2025
Immunic USD 131.96M 23.14M Sep/2026
Insmed USD 396.56M 148.2M Sep/2026
Minerva Neurosciences USD 82.3M 70.02M Dec/2025
Sangamo BioSciences USD 38.34M 13.16M Jun/2025
TherapeuticsMD 523K 89K Jun/2024